This inventor holds 3 USPTO granted patents. Top assignee: Mitsui Chemicals, Inc.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mobara, JP (1998)
- Chiba-ken, JP (1998)
Company Filing History:
Years Active: 1998
Title: Hiroshi Kohno: Innovator in Anticancer and Antiviral Agents
Introduction
Hiroshi Kohno is a prominent inventor based in Chiba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as anticancer, antiviral, and antimicrobial agents. With a total of 3 patents to his name, Kohno's work is recognized for its potential impact on medical treatments.
Latest Patents
Among his latest patents are the benzimidazole derivatives and phenylbenzimidazole derivatives. These patents describe innovative compounds that act on DNA, showcasing their potential as effective agents in combating various diseases. The active ingredients presented in these patents are designed to provide therapeutic benefits, making them valuable in the pharmaceutical industry.
Career Highlights
Kohno is currently associated with Mitsui Chemicals, Inc., where he continues to advance his research and development efforts. His work at this esteemed company has allowed him to explore new avenues in drug development, contributing to the overall mission of improving healthcare solutions.
Collaborations
Throughout his career, Kohno has collaborated with notable colleagues, including Daiji Iwata and Akio Matsunaga. These partnerships have fostered a collaborative environment that enhances innovation and drives the success of their projects.
Conclusion
Hiroshi Kohno's contributions to the field of pharmaceuticals through his innovative patents highlight his dedication to advancing medical science. His work continues to inspire future research and development in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile